And that limited access. Can I get your general opinion on peptides and your agency, your department's plans, if there are any, for maybe mainstreaming peptides? Well, We returned 12 of those peptides yesterday the class to the category one categories that formulators will now be able to formulate them. Peptides are like supplements. The FDA is only. FDA has authority to require pre licensing safety studies, pre marketing safety studies and any drug that claims a specific indication and that's mass marketed. (1:29:30–1:29:44)
CLAIM
Asserts that 12 peptides were returned to a category that allows formulators to formulate them.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
